AC Immune S.A.
ACIU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $28 | $26 | $20 | $36 |
| Short-Term Investments | $81 | $101 | $126 | $129 |
| Receivables | $0 | $2 | $3 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $3 | $4 | $5 |
| Total Curr. Assets | $114 | $132 | $152 | $172 |
| Property Plant & Equip (Net) | $7 | $7 | $8 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $50 | $50 | $50 | $50 |
| Long-Term Investments | $0 | $1 | $1 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $58 | $58 | $59 | $59 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $172 | $190 | $211 | $231 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $2 | $3 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $84 | $85 | $0 |
| Other Curr. Liab. | $96 | $11 | $11 | $97 |
| Total Curr. Liab. | $98 | $99 | $99 | $101 |
| LT Debt | $4 | $4 | $4 | $4 |
| Deferred Rev, NC | $0 | $4 | $4 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7 | $9 | $9 | $13 |
| Total NC Liab. | $11 | $17 | $17 | $18 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $5 | $5 | $5 |
| Total Liabilities | $109 | $115 | $116 | $119 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $2 | $2 | $2 |
| Retained Earnings | -$420 | -$407 | -$386 | -$368 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $480 | $479 | $479 | $478 |
| Total Equity | $62 | $75 | $95 | $112 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $172 | $190 | $211 | $231 |
| Net Debt | -$23 | -$21 | -$15 | -$31 |